Home     Font Size: 1  2  3    Send to a Friend       search

2003 News Archive

Morphotek announces successful development of antibody cell line for abgenix

December 16, 2003

Morphotek Inc. announced today that Abgenix, Inc. of Fremont, CA has confirmed the development of an antibody-producing cell line from the companies'...

+ Read the Article

Morphotek announces issuance of broad patent covering the generation of optimized yeast strains for biotherapeutic and biological product discovery, development, and manufacturing

December 15, 2003

Morphotek Inc. announced today that the United States Patent and Trademark Office has issued it U.S. Patent 6,656,736 covering the generation of...

+ Read the Article

Morphotek announces contract manufacturing and development collaboration agreement with Baxter Healthcare Corporation

October 23, 2003

Morphotek Inc. announced today that it has signed a Contract Manufacturing and Development Collaboration Agreement for use of its proprietary...

+ Read the Article

Morphotek Announces Research Collaboration and License Agreement with Novo Nordisk for Improvements to a Protein Process of a Marketed Therapeutic Protein

July 7, 2003

Morphotek Inc. today announced that it has entered into a Research Collaboration and License Agreement with Novo Nordisk (NYSE: NVO) for the use of...

+ Read the Article

Morphotek Issued Patent 6,576,468 for Platform Technology to Develop Novel Classes of Antimicrobial Agents

June 23, 2003

Morphotek Inc. announced today that the United States Patent and Trademark Office has issued it a patent covering the isolation of mutant cell lines...

+ Read the Article

Morphotek Announces Appointments to Scientific Advisory Board

June 20, 2003

Morphotek Inc. announced today the following appointments to its Scientific Advisory Board. Appointed to the Board were Dr. Matthias Wabl, Professor...

+ Read the Article

Morphotek Announces Collaborative Research Agreement with Centocor to Develop a High-Titer Antibody Cell Line for the Manfacturing of a Lead Therapeutic Antibody

January 21, 2003

Morphotek Inc. announced today that it has signed a collaborative research agreement with Centocor Inc. of Malvern, PA, a subsidiary of Johnson &...

+ Read the Article

Morphotek Announces Research Agreement with Abgenix to Develop High-Titer Antibody Cell Lines for Manufacturing

January 7, 2003

Morphotek Inc. announced today that it has signed a research agreement with Abgenix Inc. of Fremont, CA for use of its proprietary Morphodoma®...

+ Read the Article

Go to Page: 1

Results per page   10  25  50